Showing results (61-70 of 147) with videos related to
Sort By:
Pageof 15
European Journal of Haematology|November 29, 2023
Hydroxyurea at escalated dose versus fixed low-dose hydroxyurea in adults with sickle cell diseaseUgochi O Ogu, Ayesha Mukhopadhyay, Kruti Patel, et al.Hematology (Amsterdam, Netherlands)|May 8, 2014
Association of pro-inflammatory high-density lipoprotein cholesterol with clinical and laboratory variables in sickle cell diseaseKenneth I Ataga, Alan Hinderliter, Julia E Brittain, et al.Journal of Pediatric Hematology/Oncology|February 18, 2022
Enuresis and Hyperfiltration in Children With Sickle Cell DiseaseRima S Zahr, Juan Ding, Guolian Kang, et al.Pharmacotherapy|October 27, 2006
Dose-escalation study of ICA-17043 in patients with sickle cell diseaseKenneth I Ataga, Eugene P Orringer, Lori Styles, et al.American Journal of Hematology|March 23, 2026
The Longitudinal Effect of APOL1 Risk Alleles on Sickle Cell Anemia-Associated Kidney FunctionSara R Rashkin, Guolian Kang, Clifford M Takemoto, et al.British Journal of Haematology|May 16, 2023
Urinary angiotensinogen is associated with albuminuria in adults with sickle cell anaemiaLaila Elsherif, Praghalathan Kanthakumar, Jeremiah Afolabi, et al.Blood|December 31, 2002
Novel epinephrine and cyclic AMP-mediated activation of BCAM/Lu-dependent sickle (SS) RBC adhesionPatrick C Hines, Qin Zen, Sharran N Burney, et al.Haematologica|January 21, 2017
Risk factors for mortality in adult patients with sickle cell disease: a meta-analysis of studies in North America and EuropePoulami Maitra, Melissa Caughey, Laura Robinson, et al.The American Journal of Medicine|October 27, 2004
Pulmonary hypertension in sickle cell diseaseKenneth I Ataga, Namita Sood, Guy De Gent, et al.American Journal of Hematology|April 11, 2012
A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell diseaseAbdullah Kutlar, Kenneth I Ataga, Lillian McMahon, et al.Pageof 15